1. Home
  2. PDSB vs LOAN Comparison

PDSB vs LOAN Comparison

Compare PDSB & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

SELL

Current Price

$1.25

Market Cap

42.4M

Sector

Health Care

ML Signal

SELL

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$3.31

Market Cap

38.8M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDSB
LOAN
Founded
2005
1989
Country
United States
United States
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
42.4M
38.8M
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
PDSB
LOAN
Price
$1.25
$3.31
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $4.50
N/A
AVG Volume (30 Days)
★ 8.0M
34.2K
Earning Date
11-20-2026
10-21-2026
Dividend Yield
N/A
★ 13.29%
EPS Growth
★ 28.16
N/A
EPS
N/A
★ 0.32
Revenue
N/A
★ $8,666,307.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$10.63
Revenue Growth
★ N/A
N/A
52 Week Low
$0.20
$3.31
52 Week High
$1.79
$5.01

Technical Indicators

Market Signals
Indicator
PDSB
LOAN
Relative Strength Index (RSI) 54.53 37.34
Support Level $0.60 $3.31
Resistance Level $1.32 $4.50
Average True Range (ATR) 0.19 0.08
MACD -0.01 0.01
Stochastic Oscillator 48.74 25.00

Price Performance

Historical Comparison
PDSB
LOAN

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: